Dozens of commonly prescribed medications can trigger delirium, a sudden change in mental function marked by confusion, difficulty paying attention, and disturbed awareness of surroundings. The drug classes most frequently implicated include anticholinergics, benzodiazepines, opioids, and corticosteroids, though the list extends well beyond those four. Recognizing the signs matters because delirium often goes undetected, particularly when it makes a person quiet and withdrawn rather than agitated.
What Delirium Actually Looks Like
Delirium is not a single look or behavior. Clinicians divide it into three motoric subtypes: hyperactive, hypoactive, and mixed. Hyperactive delirium is what most people picture. The person is restless, agitated, may pull at IV lines, and can experience vivid hallucinations or delusions. Hypoactive delirium is the opposite and far sneakier. The person seems drowsy, sluggish, and unresponsive, which hospital staff sometimes mistake for depression or simple fatigue. Mixed delirium swings between both states. In one large study of critically ill patients, the mixed form was the most common at roughly 55%, followed by hypoactive at about 44%, while purely hyperactive delirium accounted for less than 2%.1PubMed. Delirium and its motoric subtypes: a study of 614 critically ill patients Patients 65 and older were especially likely to develop the hypoactive form and in that study never experienced purely hyperactive delirium.
Across all subtypes, certain core features are consistent. The onset is acute, developing over hours to a couple of days rather than weeks. Attention is always impaired: the person cannot follow a conversation, loses track of questions, or drifts mid-sentence. Thinking becomes disorganized, with rambling speech, illogical ideas, or an inability to stay on topic. The level of consciousness fluctuates, sometimes within the same hour. Sleep-wake cycles are often disrupted, with the person dozing during the day and becoming confused or agitated at night. In hyperactive presentations, delusions, mood swings, and hallucinations tend to be more prominent.2PubMed. Relationship between symptoms and motoric subtype of delirium
How Clinicians Detect It
The most widely used bedside tool is the Confusion Assessment Method, or CAM. It was designed to be quick and practical, taking less than five minutes. The CAM flags delirium when two features are present: an acute onset with a fluctuating course, and inattention. On top of those, at least one more feature must appear, either disorganized thinking or an altered level of consciousness.3PubMed. Clarifying confusion: the confusion assessment method. A new method for detection of delirium When used by trained assessors alongside formal cognitive testing, a systematic review combining seven high-quality studies found the CAM had a sensitivity of about 94% and specificity of about 89%.4PubMed Central. The Confusion Assessment Method: a systematic review of current usage Versions have been adapted for intensive care units, emergency departments, and nursing homes.
Performance drops, though, when the tool is used casually or without cognitive testing. That matters because the hypoactive subtype, which is the most common in older adults, is the easiest to miss. A patient who is quiet and confused looks very different from one who is thrashing in bed, and busy clinical settings sometimes catch only the dramatic presentations.
How Drugs Cause Delirium in the Brain
No single mechanism explains all drug-induced delirium, but the neurotransmitter most consistently implicated is acetylcholine. The brain relies on acetylcholine for attention, memory, and awareness. When drugs block acetylcholine receptors or reduce its availability, the result can be acute confusion.5PubMed Central. Cholinergic deficiency hypothesis in delirium: a synthesis of current evidence At the same time, excess dopamine, norepinephrine, or glutamate activity can push the brain toward delirium from the other direction. Other neurotransmitters, including serotonin and GABA, may swing in either direction depending on the drug and the type of delirium involved.6PubMed. Neuropathogenesis of delirium: review of current etiologic theories and common pathways Inflammation and blood-brain barrier disruption also play roles, which helps explain why delirium so often accompanies infections and surgery rather than drugs alone.
Anticholinergic Drugs
Anticholinergics sit at the top of the risk list precisely because they strike at acetylcholine, the neurotransmitter most central to maintaining clear thinking. What makes this category tricky is how many everyday medications carry anticholinergic activity. Obvious culprits include bladder-control drugs like oxybutynin and older antihistamines like diphenhydramine (Benadryl). Less obvious ones include certain antidepressants, muscle relaxants, and antipsychotics. Many of these are available without a prescription.
Risk rises with the total anticholinergic load a person is taking. In hospitalized older adults, those whose combined anticholinergic burden scored three or higher on a standard rating scale had roughly three to six times the risk of delirium compared with patients not taking anticholinergic drugs.7PubMed. Relation Between Delirium and Anticholinergic Drug Burden in a Cohort of Hospitalized Older Patients: An Observational Study A systematic review confirmed the pattern: higher anticholinergic burden was consistently linked to delirium across multiple measurement tools.8PubMed. Anticholinergic Drug Burden and Delirium: A Systematic Review The relationship held in nursing home residents both with and without dementia, though it was most pronounced among those who already had dementia.9Journal of the American Medical Directors Association. Association Between Anticholinergic Medication Burden and Delirium in Nursing Home Patients with and without Dementia
The practical takeaway is that it is rarely a single anticholinergic pill that causes trouble. It is the accumulation. A person taking a bladder drug, an over-the-counter sleep aid, and an older antidepressant may be stacking three mild anticholinergic agents into a combined dose strong enough to tip the brain into delirium, especially if they are older, dehydrated, or recovering from surgery.
Benzodiazepines and Other Sedatives
Benzodiazepines, the class that includes drugs like midazolam, lorazepam, and diazepam, are among the most well-documented delirium triggers in hospital settings. In critically ill adults, giving a benzodiazepine to a patient who was awake and clear increased the odds of delirium the following day. The risk was higher with continuous infusion than with occasional doses.10PubMed. Benzodiazepine-associated delirium in critically ill adults In older ICU patients, receipt of a benzodiazepine or opioid was associated with longer-lasting delirium.11PubMed Central. Benzodiazepine and opioid use and the duration of ICU delirium in an older population
This is why ICU sedation practices have shifted. Midazolam, once the go-to sedative for ventilated patients, has fallen out of favor in many units. A network meta-analysis comparing sedative agents found that midazolam was associated with a significantly higher rate of postoperative delirium, while dexmedetomidine, a different type of sedative, was the most effective option for reducing it.12PubMed. The effect of perioperative anesthetics for prevention of postoperative delirium on general anesthesia: A network meta-analysis Dexmedetomidine works through a different pathway, affecting norepinephrine rather than GABA, and produces a lighter, more arousable sedation that seems less disruptive to the brain.
Opioids
Pain medications like morphine, oxycodone, and fentanyl occupy an awkward position in delirium risk. They can clearly cause delirium, but untreated severe pain is itself a delirium trigger, so withholding them is not always the safer option. The risk appears to be dose-dependent. In a registry study of patients with advanced cancer, opioid use roughly doubled the odds of delirium, and high-dose opioid use increased it nearly sixfold compared with no opioid use.13Scientific Reports. Opioid use and subsequent delirium risk in patients with advanced cancer in palliative care: a multicenter registry study
Whether one opioid is safer than another in terms of delirium is less clear. A study comparing morphine, oxycodone, and tramadol in patients who had never taken opioids before found delirium rates of roughly 5% to 7% across all three, with no statistically significant difference among them.14PubMed Central. Incidence of Delirium With Different Oral Opioids in Previously Opioid-Naive Patients The implication is that dosage and patient vulnerability matter more than the specific opioid chosen. Rapid dose increases seem to be particularly risky.15PubMed. Treatment of opioid-induced delirium with acetylcholinesterase inhibitors: a case report
Corticosteroids
Steroids like prednisone, dexamethasone, and methylprednisolone are prescribed for everything from asthma flares to cancer treatment. Their neuropsychiatric side effects, including insomnia, mood swings, psychosis, and delirium, have been recognized for decades.16PubMed Central. Steroid-Induced Sleep Disturbance and Delirium: A Focused Review for Critically Ill Patients The risk tracks with dose: higher corticosteroid doses produce more psychiatric effects.17PubMed. Steroid psychosis: a review
A common scenario is a patient admitted with a severe asthma exacerbation or a COPD flare, started on high-dose intravenous steroids, who becomes agitated and confused within a day or two. The confusion usually resolves as the steroid dose tapers down, but in the meantime it can complicate care and extend hospital stays. Stopping steroids abruptly can also trigger problems, so dose reductions need to be gradual.
Cardiovascular Drugs and Other Culprits
Some heart medications carry underappreciated delirium risk. Certain antiarrhythmic drugs have been linked to delirium, and digitalis (digoxin) toxicity can produce hallucinations, mania, and confusion.18Cardiology in Review. Neuropsychiatric Effects of Cardiovascular Drug Therapy Beta-blockers that cross the blood-brain barrier, like propranolol, have occasionally been linked to confusion in older adults as well. The risk from any single cardiovascular drug is usually small on its own, but in an older patient already taking an anticholinergic or a sedative, adding one more brain-active drug can be the factor that tips things over.
Beyond these major categories, anticonvulsants, certain antibiotics (fluoroquinolones are a frequent offender), and even some anti-nausea medications with anticholinergic or dopamine-related activity round out the list. The common thread is that any drug affecting neurotransmitter balance in a vulnerable brain can contribute.
Withdrawal as a Cause of Delirium
Delirium does not always come from taking a drug. It can also come from stopping one. Alcohol withdrawal is the most dramatic example. Delirium tremens, or DT, represents the most severe end of the alcohol withdrawal spectrum and can be fatal without treatment.19PubMed Central. Delirium Tremens: Assessment and Management It typically appears two to three days after the last drink in someone with a history of heavy, sustained alcohol use.20PubMed Central. Alcohol withdrawal syndrome: mechanisms, manifestations, and management Symptoms include severe agitation, tremors, vivid hallucinations, fever, and dangerously elevated heart rate and blood pressure.
Benzodiazepine withdrawal can produce a similar picture, especially in people who have used them daily for months or years. This creates an uncomfortable clinical dilemma: benzodiazepines cause delirium when given, and their abrupt removal causes delirium too. The answer is usually a carefully managed taper rather than a sudden stop. Barbiturate withdrawal, though less common today, follows the same pattern.
Surgery, Anesthesia, and the ICU
Postoperative delirium is one of the most common complications in older surgical patients. It develops in the days following an operation, and while the surgery itself, along with pain, sleep deprivation, and inflammation, does most of the triggering, anesthetic drugs play a role. Research suggests that the type of surgery matters more than the type of anesthesia for overall delirium risk, but the depth of anesthesia may influence longer-term cognitive effects.21PubMed Central. Post-Operative Delirium in Elderly Patients: A Narrative Review Among anesthetic agents, dexmedetomidine has shown promise for both preventing and treating hyperactive postoperative delirium.
Emerging research points to disruption of the blood-brain barrier as a key mechanism in postoperative delirium. Markers of barrier leakage and brain inflammation rose in surgical patients who developed delirium and correlated with its severity.22PubMed Central. Postoperative delirium and changes in the blood–brain barrier, neuroinflammation, and cerebrospinal fluid lactate: a prospective cohort study In critically ill patients more broadly, markers of endothelial damage and blood-brain barrier injury at the time of admission predicted both the likelihood and duration of delirium.23PubMed Central. Endothelial Activation and Blood-Brain Barrier Injury as Risk Factors for Delirium in Critically Ill Patients This helps explain why infection, surgery, and inflammation are such potent delirium triggers: they attack the brain’s protective barrier, allowing inflammatory signals and toxins to reach neurons that are normally shielded.
Distinguishing Delirium from Dementia
One of the biggest practical challenges is telling delirium apart from dementia, especially because many patients who develop delirium already have dementia. Both involve confusion and cognitive impairment, but delirium arrives suddenly and fluctuates, while dementia develops gradually and remains relatively stable day to day. The hallmark distinguishing feature at the bedside is attention. In a study comparing hospitalized older adults with delirium alone, dementia alone, and both conditions together, delirium groups stood out from the dementia-only group primarily on non-cognitive symptoms and on impaired attention specifically, rather than on other cognitive measures.24BMJ Open. Comparison of cognitive and neuropsychiatric profiles in hospitalised elderly medical patients with delirium, dementia and comorbid delirium–dementia
When a person with known dementia suddenly becomes much worse, with new hallucinations, dramatic fluctuations in alertness, or severe inattention, delirium superimposed on dementia is the likely explanation. This combination is not just common; it carries a particularly poor prognosis. The overlap also means that any new medication added to a dementia patient’s regimen deserves extra scrutiny for delirium-causing potential.
Why Delirium Has Consequences Beyond the Episode
Delirium was once treated as a temporary nuisance that would resolve once the underlying cause was fixed. The evidence now says otherwise. A neuropathological study combining three large population-based cohorts found that delirium accelerated cognitive decline at a rate comparable to the pathological changes of dementia itself. Worse, when delirium occurred in someone who already had dementia pathology in their brain, the two multiplied each other’s effects, producing the fastest decline of all.25PubMed Central. Association of Delirium With Cognitive Decline in Late Life: A Neuropathologic Study of 3 Population-Based Cohort Studies
In a study following older adults for six years after major surgery, those who experienced postoperative delirium showed a meaningfully faster decline in general cognitive performance compared with those who did not develop delirium.26JAMA Internal Medicine. Six-Year Cognitive Trajectory in Older Adults Following Major Surgery and Delirium This makes drug-induced delirium more than a short-term problem. Every episode may leave the brain slightly more vulnerable to future decline, which raises the stakes for preventing it in the first place.
The Psychological Aftermath
Beyond cognitive decline, delirium can leave a psychological mark. Patients who experience delirium often have poor factual recall of what happened during their hospital stay, but they may retain vivid memories of hallucinations and delusions that felt terrifying at the time. This mismatch, remembering frightening things that did not happen while forgetting the real events, has been linked to symptoms resembling post-traumatic stress.27PubMed. Post-traumatic Stress Disorder Following Acute Delirium Whether this rises to a clinical diagnosis of PTSD is debated, and at least one study found that ICU delirium did not increase PTSD symptom scores at two and six months after discharge.28PubMed Central. Symptoms of Posttraumatic Stress after Intensive Care Delirium Still, families frequently describe personality changes, anxiety, and sleep disturbances in the weeks and months after a delirium episode, even when formal diagnostic criteria for PTSD are not met.
Reducing Drug-Induced Delirium Risk
The most straightforward strategy is reducing the number of delirium-prone drugs a person takes, particularly anticholinergics and benzodiazepines. This concept, known as deprescribing, sounds simple but turns out to be hard to implement. A randomized trial in the ICU found that even with a structured deprescribing intervention added on top of good clinical care, there was no measurable impact on how many anticholinergics or benzodiazepines patients ended up receiving.29PubMed Central. Deprescribing in the Pharmacologic Management of Delirium: A Randomized Trial in the Intensive Care Unit The authors noted the need for better approaches, suggesting that current workflows and prescribing habits are deeply entrenched.
Non-drug prevention strategies tend to be more effective in practice. Ensuring adequate hydration and nutrition, correcting electrolyte imbalances, preserving sleep-wake cycles with daytime light and nighttime quiet, encouraging mobility, and keeping the patient oriented with clocks, calendars, and familiar faces all reduce delirium rates. When medications are necessary, choosing the least deliriogenic option at the lowest effective dose makes a real difference. For sedation in the ICU, favoring dexmedetomidine over benzodiazepines is now a widely accepted recommendation. For pain, using multimodal approaches that limit opioid doses rather than relying on opioids alone reduces the total exposure.
Newer Drugs on the Radar
As cancer treatment evolves, new drug-related triggers for delirium are emerging. CAR T-cell therapy, a form of immunotherapy used for certain blood cancers, can produce a neurological complication known as immune effector cell-associated neurotoxicity syndrome, or ICANS. The most common presentations of ICANS include delirium and language impairment.30PubMed Central. EEG Correlates of Delirium in Children and Young Adults With CD19-Directed CAR T Cell Treatment-Related Neurotoxicity In one pediatric study, neurotoxicity occurred in about 44% of patients treated with CAR T-cells, with reversible delirium among the most commonly observed symptoms.31PubMed Central. Glial injury in neurotoxicity after pediatric CD19-directed chimeric antigen receptor T cell therapy ICANS can also encompass seizures, psychosis, and in severe cases cerebral edema.32PubMed Central. Immune Effector Cell-Associated Neurotoxicity Syndrome After CAR T-Cell Therapy and Other Psychiatric Manifestations: A Review and Case Series The mechanism is different from traditional drug-induced delirium since it is driven by an immune response rather than direct neurotransmitter blockade, but the bedside presentation looks remarkably similar, meaning the same screening tools and clinical vigilance apply.